Company: BDRX
Filing Date: 2025-05-08
Form Type: POS AM
Source: 0001214659-25-007201
Chunk: 109

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-05-08
Form: POS AM
Chunk 109
---
                   |     |                    |   383,770,000 |     |                    | 297,860,000 |     |                    |  85,910,000 |     |                |   * |
| Ionic Ventures, LLC (8)                       |     |                    | 1,160,720,000 |     |                    | 851,060,000 |     |                    | 309,660,000 |     |                | 1.2 |
| Mercer Street Global Opportunity Fund LLC (9) |     |                    |   324,810,000 |     |                    |   8,500,000 |     |                    | 316,310,000 |     |                | 1.2 |
| Ladenburg Thalmann & Co., Inc. (10)           |     |                    |   112,880,000 |     |                    |  34,110,000 |     |                    |  78,770,000 |     |                |   * |
| Nicholas Stergis (11)                         |     |                    |    74,490,000 |     |                    |  42,210,000 |     |                    |  32,280,000 |     |                |   * |
| David Coherd (12)                             |     |                    |     9,630,000 |     |                    |   5,110,000 |     |                    |   4,520,000 |     |                |   * |
| Andrew Moorefield (13)                        |     |                    |            -- |     |                    |   2,550,000 |     |                    |          -- |     |                |  -- |
| Mark Weinberger (14)                          |     |                    |     3,200,000 |     |                    |   1,270,000 |     |                    |   1,930,000 |     |                |   * |

__________________

* Represents beneficial ownership of less than 1%.

**Subject to beneficial ownership blocker.

*** Based upon 25,617,408,922Ordinary
Shares issued and outstanding as of April 1, 2025.

| (1) | Assumes                                                                                                                                     
 that all Ordinary Shares being registered under the registration statement of which this prospectus forms a part are sold in this offering, 
 and that none of the selling stockholders acquire additional Ordinary Shares after the date of this prospectus and prior